JCR Pharmaceuticals Co., Ltd. (TYO:4552)
Japan
· Delayed Price · Currency is JPY 622.00
+12.00 (1.97%)
Mar 10, 2026, 10:04 AM JST
JCR Pharmaceuticals Ratios and Metrics
Market cap in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 74,412 | 58,963 | 107,204 | 176,306 | 279,312 | 443,148 | Upgrade
|
| Market Cap Growth | 14.81% | -45.00% | -39.19% | -36.88% | -36.97% | 52.60% | Upgrade
|
| Enterprise Value | 111,806 | 76,238 | 112,497 | 181,176 | 266,306 | 440,087 | Upgrade
|
| Last Close Price | 610.00 | 476.45 | 818.17 | 1320.78 | 2085.97 | 3283.79 | Upgrade
|
| PE Ratio | - | - | 19.47 | 46.74 | 19.25 | 64.30 | Upgrade
|
| Forward PE | 42.08 | 18.68 | 15.47 | 25.97 | 25.23 | 65.14 | Upgrade
|
| PS Ratio | 1.98 | 1.78 | 2.50 | 5.13 | 5.47 | 14.73 | Upgrade
|
| PB Ratio | 1.59 | 1.24 | 1.90 | 3.36 | 5.47 | 11.49 | Upgrade
|
| P/TBV Ratio | 1.70 | 1.34 | 2.04 | 3.63 | 5.83 | 12.61 | Upgrade
|
| P/FCF Ratio | - | - | 13.77 | - | - | 79.69 | Upgrade
|
| P/OCF Ratio | - | - | 11.51 | - | 30.07 | 42.85 | Upgrade
|
| PEG Ratio | - | 1.78 | 1.78 | 1.78 | 1.78 | 1.78 | Upgrade
|
| EV/Sales Ratio | 2.98 | 2.31 | 2.62 | 5.28 | 5.21 | 14.63 | Upgrade
|
| EV/EBITDA Ratio | - | - | 10.49 | 25.98 | 12.17 | 43.23 | Upgrade
|
| EV/EBIT Ratio | - | - | 14.94 | 36.40 | 13.36 | 53.09 | Upgrade
|
| EV/FCF Ratio | - | - | 14.45 | - | - | 79.14 | Upgrade
|
| Debt / Equity Ratio | 1.13 | 0.80 | 0.41 | 0.44 | 0.35 | 0.47 | Upgrade
|
| Debt / EBITDA Ratio | - | - | 2.17 | 3.27 | 0.83 | 1.78 | Upgrade
|
| Debt / FCF Ratio | - | - | 2.99 | - | - | 3.26 | Upgrade
|
| Net Debt / Equity Ratio | 0.79 | 0.53 | 0.08 | 0.18 | -0.25 | -0.21 | Upgrade
|
| Net Debt / EBITDA Ratio | -17.42 | -7.18 | 0.42 | 1.37 | -0.59 | -0.80 | Upgrade
|
| Net Debt / FCF Ratio | - | -1.62 | 0.58 | -0.72 | 6.30 | -1.47 | Upgrade
|
| Asset Turnover | 0.34 | 0.32 | 0.44 | 0.36 | 0.60 | 0.50 | Upgrade
|
| Inventory Turnover | 0.45 | 0.53 | 0.59 | 0.54 | 0.74 | 0.70 | Upgrade
|
| Quick Ratio | 0.61 | 0.58 | 1.12 | 0.68 | 1.11 | 1.19 | Upgrade
|
| Current Ratio | 1.16 | 1.16 | 1.91 | 1.34 | 1.48 | 1.67 | Upgrade
|
| Return on Equity (ROE) | -4.86% | -9.04% | 10.17% | 7.32% | 32.39% | 19.37% | Upgrade
|
| Return on Assets (ROA) | -3.21% | -4.13% | 4.78% | 3.24% | 14.58% | 8.52% | Upgrade
|
| Return on Invested Capital (ROIC) | -7.18% | -10.26% | 9.36% | 6.96% | 43.48% | 21.80% | Upgrade
|
| Return on Capital Employed (ROCE) | -8.90% | -11.20% | 10.40% | 8.40% | 36.20% | 18.50% | Upgrade
|
| Earnings Yield | -3.28% | -8.07% | 5.14% | 2.14% | 5.19% | 1.55% | Upgrade
|
| FCF Yield | - | -26.07% | 7.26% | -7.46% | -0.73% | 1.26% | Upgrade
|
| Dividend Yield | 3.21% | 4.20% | 2.44% | 1.51% | 0.96% | 0.35% | Upgrade
|
| Payout Ratio | - | - | 45.40% | 72.61% | 14.95% | 15.71% | Upgrade
|
| Buyback Yield / Dilution | 2.06% | 1.25% | -0.45% | -0.51% | -0.06% | -0.07% | Upgrade
|
| Total Shareholder Return | 5.27% | 5.45% | 2.00% | 1.01% | 0.90% | 0.28% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.